New drug for Kids' bleeding disorder under watch
NCT ID NCT07404644
Summary
This study is monitoring the safety and effectiveness of a drug called vonicog alfa (rVWF) in children under 18 with Von Willebrand disease, a condition that causes excessive bleeding. Doctors will give the drug as usual treatment for bleeding episodes or around surgery, and researchers will track any side effects and how well it works for one year. The goal is to gather real-world information on how this drug performs in pediatric patients in Japan.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VON WILLEBRAND DISEASE (VWD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Takeda selected site
RECRUITINGTokyo, Tokyo, Japan
Conditions
Explore the condition pages connected to this study.